BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 23, 2017
View Archived Issues
Telix announces product development partnership with Therapeia for ACD-101
Read More
Innovate UK grant supports Ubiquigent's development of compound libraries targeting DUB enzymes
Read More
Merck & Co. describes novel PDE2A inhibitors
Read More
Immuron begins mechanism of action studies on IMM-124E for NASH
Read More
Bristol-Myers Squibb patents novel indoleamine 2,3-dioxygenase 1 inhibitors
Read More
The University of Michigan discovers GRK2, GRK5 inhibitors
Read More
Janssen discloses new sulfamoylarylamide derivatives for HBV infection
Read More
Genentech and Roche present novel PI3Kalpha and PI3Kdelta inhibitors
Read More
D9-ivacaftor granted U.S. orphan designation for cystic fibrosis
Read More
REGN-2477 receives FDA orphan designation for fibrodysplasia ossificans progressiva
Read More
Corvus Pharmaceuticals presents overview of pipeline
Read More
Zydus Cadila acquires Sentynl Therapeutics
Read More
Voyager Therapeutics provides update on phase Ib study of gene therapy for Parkinson's
Read More
Minerva Neurosciences gives results from additional data analyses on phase IIb MIN-101 study
Read More
Takeda identifies the first GPX4 inhibitory peptide
Read More
Simmiparib demonstrates favorable pharmacokinetic profile and in vivo anticancer activity
Read More
First patient dosed in phase Ib study of OncoMed's brontictuzumab
Read More
NeuroVive signs preclinical collaboration agreement with CHOP for mitochondrial disorders
Read More
Gilead Sciences' MAA for sofosbuvir/velpatasvir/voxilaprevir validated by EMA
Read More
ADI-PEG20 well tolerated with nab-paclitaxel and gemcitabine in pancreatic cancer trial
Read More
Actelion reports findings from phase III study of macitentan in PAH due to Eisenmenger syndrome
Read More
Trametinib studied with 5-fluorouracil and chemoradiation in rectal cancer trial
Read More
New Innovate UK award supports Cypralis' development of cyclophilin D inhibitors
Read More
Jazz Pharmaceuticals reviews pipeline outlook
Read More
Incyte advances INCB-050465 into phase II for relapsed or refractory DLBCL
Read More
NIAID studies Zika virus DNA vaccine in phase I trial
Read More